您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版)

• 临床医学 • 上一篇    下一篇

PARP-1对卵巢癌血管生成的影响

李燕,尉蔚,吕树卿,田永杰   

  1. 山东大学附属省立医院妇产科,山东 济南 250021
  • 收稿日期:2013-12-02 出版日期:2014-04-10 发布日期:2014-04-10
  • 通讯作者: 田永杰 E-mail:tianyongjie@sdu.edu.cn
  • 基金资助:
    山东省科技发展计划资助项目(2012 GSF11821)

Effects of PARP-1 on angiogenesis of ovarian cancer

LI Yan, WEI Wei, LV Shuqing, TIAN Yongjie   

  1. Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2013-12-02 Online:2014-04-10 Published:2014-04-10

摘要: 目的  观察上皮性卵巢癌中聚腺苷酸二磷酸核糖聚合酶-1(PARP-1)表达与血管内皮生长因子-A(VEGF-A)、微血管密度(MVD)的关系,探讨PARP-1对卵巢癌血管生成的影响。方法  采用免疫组织化学SP法检测60例上皮性卵巢癌原发灶中PARP-1、VEGF-A、MVD的表达以及30例正常卵巢对照组织中PARP-1的表达,根据组化结果  判定标准将卵巢癌组织分为PARP-1阳性组和PARP-1阴性组。RNA干扰沉默卵巢癌SKOV3细胞的PARP-1基因,将细胞分为转染阴性对照siRNA组(NC-siRNA组)、转染PARP-1 siRNA组(PARP1-siRNA组),观察对脐静脉内皮细胞(HUVEC)体外成管的影响,ELISA法检测转染后细胞VEGF-A的表达水平。 结果  卵巢癌组织中PARP-1阳性率为73.3%(44/60),正常卵巢对照组织中PARP-1阳性率为26.7%(8/30),差异有统计学意义(P<0.05)。PARP-1表达与肿块大小、病理分级和淋巴结转移具有相关性;PARP-1表达与VEGF-A表达呈正相关(P<0.05);PARP-1阳性组MVD值显著高于PARP-1阴性组(P<0.01);体外成管数目NC-siRNA组(14.67±1.21)高于PARP1-siRNA组(8.83±1.47),差异有统计学意义(P<0.01);PARP1-siRNA组细胞VEGF-A的表达显著低于NC-siRNA组(P<0.01)。结论  PARP-1通过调控VEGF-A的表达影响卵巢癌的血管生成。

关键词: 聚腺苷酸二磷酸核糖聚合酶-1, 微血管密度, 卵巢癌, 血管内皮生长因子-A, 小干扰RNA, 血管生成

Abstract: Objective  To investigate the expression of Poly (ADP-ribose) polymerase-1(PARP-1) and its relationship with vascular endothelial growth factor-A (VEGF-A) and microvessel density (MVD) in epithelial ovarian cancer tissues, and to further explore the effect of PARP-1 on the angiogenesis of ovarian cancer. Methods  Expressions of PARP-1, VEGF-A and MVD in 60 cases of epithelial ovarian cancer tissues and expression of PARP-1 in 30 cases of normal ovarian tissues were detected by immunohistochemical technology (SP). Ovarian cancer tissues were divided into PARP-1 positive group and PARP-1 negative group with reference to the assessment criteria of immunohistochemical staining.  SKOV3 cells were transfected with either negative control siRNA (NC-siRNA group) or PARP-1 siRNA (PARP1-siRNA group), and tube formation assay in vitro was used to determine the angiogenesis capacity. Expression of VEGF-A in supernatants of SKOV3 cells post transfection was tested by ELISA. Results  Positive rate of PARP-1 in ovarian cancer tissues (44/60, 73.3%) was significantly higher than that in the normal ovarian tissues (8/30, 26.7%) (P<0.05). In ovarian cancer, expression of PARP-1 was associated with tumor size, histological grade and lymphatic metastasis. Expression of PARP-1 was positively correlated with VEGF-A (P<0.05). MVD value was significantly higher in PARP-1 positive group than in the negative group (P<0.01). Tube density in NC-siRNA group (14.67±1.21) was higher than that in PARP1-siRNA group (8.83±1.47) (P<0.01). Expression of VEGF-A in NC-siRNA group and PARP1-siRNA group was significantly different (P<0.01). Conclusion  PARP-1 may promote the angiogenesis of ovarian cancer by up-regulating the expression of VEGF-A.

Key words: Angiogenesis, Ovarian cancer, Poly (ADP-ribose) polymerase-1, siRNA, Vascular endothelial growth factor-A, Microvessel density

中图分类号: 

  • R737.31
[1] 于德新 蔡跃红 马祥兴 张晓明 李传福. 肝细胞癌血管生成及其成熟度的临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 51-54.
[2] 杜艾家,张曼,陈鹤,王丽新,尚应殊. 微小RNA-1270靶向调控血管生成素样蛋白7抑制巨噬细胞炎症和脂质蓄积[J]. 山东大学学报 (医学版), 2025, 63(2): 1-9.
[3] 袁宗怀,潘广晔,迟曰梅,安传国,张永刚. 孟德尔随机化分析低级别浆液性卵巢癌与乳腺癌的因果关系[J]. 山东大学学报 (医学版), 2025, 63(1): 99-107.
[4] 何静,严如根,武志红,李长忠. 消癥抑癌方对卵巢癌SKOV3细胞增殖、迁移的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 1-10.
[5] 焦光丽,石子馨,陈蓉,宋亚博,杨飞,崔书君. 基于增强CT影像组学预测卵巢癌患者铂类药物敏感性[J]. 山东大学学报 (医学版), 2023, 61(12): 62-69.
[6] 华月帆,何珂瑶,张家豪,钱梦凡,刘怡文,孔金玉,杨海军,周福有. 具核梭杆菌诱导缺氧诱导因子及血管生成因子高表达对食管鳞癌患者生存预后的影响[J]. 山东大学学报 (医学版), 2023, 61(11): 59-67.
[7] 秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82.
[8] 张艺馨,赵玉立,封丽. 超声特征及术前CA-125联合对51例卵巢交界性及Ⅰ期恶性肿瘤的鉴别诊断[J]. 山东大学学报 (医学版), 2022, 60(7): 104-109.
[9] 孙丽娜,杜晓晓,张红娟,孟金来. 人类白细胞抗原G调控蜕膜自然杀伤细胞促进滋养细胞侵袭[J]. 山东大学学报 (医学版), 2022, 60(6): 41-45.
[10] 林雪艳,张灿灿,田民乐,田永杰. 聚腺苷酸二磷酸核糖聚合酶-1在子宫内膜异位症中的表达及意义[J]. 山东大学学报 (医学版), 2022, 60(2): 27-31.
[11] 哈春芳,李茹月. 卵巢癌耐药机制与靶向治疗策略的研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 117-123.
[12] 曹义海. 血管生成在疾病治疗中的应用与展望[J]. 山东大学学报 (医学版), 2021, 59(9): 9-14.
[13] 陈君宇, 曹冬焱. 以脑梗为首发的卵巢癌病例报告[J]. 山东大学学报 (医学版), 2021, 59(5): 110-112.
[14] 王正阳,夏艳,师凯旋,陶琨,王小杰. 曲美替尼在卵巢癌中对PAX8的表达作用[J]. 山东大学学报 (医学版), 2021, 59(10): 25-31.
[15] 王宝金,赵欣欣,李霞,马倩,王新月,孙阳,史中娜. miR-203靶向Survivin抑制卵巢癌细胞增殖、迁移与侵袭[J]. 山东大学学报 (医学版), 2020, 58(12): 23-28.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!